Takasago International Corporation (4914):企業の財務・戦略的SWOT分析

◆英語タイトル:Takasago International Corporation (4914) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C2593
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:38
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:消費財
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Takasago International Corporation (4914) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Takasago International Corporation (Takasago) is a flavor and fragrances company, which manufactures and sells flavors and fragrances for fine fragrance, personal care products, food, beverage, and household products. It also offers a range of fine chemicals to pharmaceutical and chemical companies. Takasago specializes in the areas of additional reaction, asymmetric hydrogenation, deamination, elimination reaction, esterification, hydrogenation, hydrolysis, polymerization depolymerization and telomerization. It is one of the leading companies in asymmetric synthesis of menthol-derived sensory materials. The company has its presence in major markets of Asia-Pacific, EMEA and Americas through a network of research, production and marketing facilities. Takasago is headquartered in Tokyo, Japan.

Takasago International Corporation Key Recent Developments

May 15,2017: Takasago International reports consolidated financial statement for fiscal year ended 31 March 2017
Feb 13,2017: Takasago reports consolidated financial statements for Q3 of fiscal year ended 31 March 2017

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
Takasago International Corporation – Key Facts 6
Takasago International Corporation – Key Employees 7
Takasago International Corporation – Key Employee Biographies 8
Takasago International Corporation – Major Products and Services 9
Takasago International Corporation – History 10
Takasago International Corporation – Company Statement 12
Takasago International Corporation – Locations And Subsidiaries 14
Head Office 14
Other Locations & Subsidiaries 14
Section 2 – Company Analysis 16
Company Overview 16
Takasago International Corporation – Business Description 17
Business Segment: Fine Chemicals 17
Overview 17
Performance 17
Business Segment: Flavors 17
Overview 17
Performance 17
Business Segment: Fragrances 18
Overview 18
Performance 18
Business Segment: Others 18
Overview 18
Performance 18
Takasago International Corporation – Corporate Strategy 19
Takasago International Corporation – SWOT Analysis 20
SWOT Analysis – Overview 20
Takasago International Corporation – Strengths 20
Takasago International Corporation – Weaknesses 21
Takasago International Corporation – Opportunities 22
Takasago International Corporation – Threats 23
Takasago International Corporation – Key Competitors 24
Section 3 – Company Financial Ratios 25
Financial Ratios – Capital Market Ratios 25
Financial Ratios – Annual Ratios 26
Performance Chart 29
Financial Performance 29
Financial Ratios – Interim Ratios 30
Financial Ratios – Ratio Charts 31
Section 4 – Company’s Recent Developments 32
May 15, 2017: Takasago International reports consolidated financial statement for fiscal year ended 31 March 2017 32
Feb 13, 2017: Takasago reports consolidated financial statements for Q3 of fiscal year ended 31 March 2017 33
Section 5 – Appendix 34
Methodology 34
Ratio Definitions 34
About GlobalData 38
Contact Us 38
Disclaimer 38

List of Tables
Takasago International Corporation, Key Facts 6
Takasago International Corporation, Key Employees 7
Takasago International Corporation, Key Employee Biographies 8
Takasago International Corporation, Major Products and Services 9
Takasago International Corporation, History 10
Takasago International Corporation, Subsidiaries 14
Takasago International Corporation, Key Competitors 24
Takasago International Corporation, Ratios based on current share price 25
Takasago International Corporation, Annual Ratios 26
Takasago International Corporation, Annual Ratios (Cont...1) 27
Takasago International Corporation, Annual Ratios (Cont...2) 28
Takasago International Corporation, Interim Ratios 30
Currency Codes 34
Capital Market Ratios 34
Equity Ratios 35
Profitability Ratios 35
Cost Ratios 36
Liquidity Ratios 36
Leverage Ratios 37
Efficiency Ratios 37

List of Figures
Takasago International Corporation, Performance Chart (2014 - 2018) 29
Takasago International Corporation, Ratio Charts 31

★海外企業調査レポート[Takasago International Corporation (4914):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Profectus BioSciences Inc-製薬・医療分野:企業M&A・提携分析
    Summary Profectus BioSciences Inc (Profectus), formerly Maryland Biotherapeutics Inc is a clinical-stage vaccine development company that designs and develops vaccines for infectious diseases and oncolytic vaccines for cancer immunotherapy. The company's products comprise genevax therapeutic vaccine …
  • Vera Bradley Inc:企業の戦略・SWOT・財務分析
    Vera Bradley Inc - Strategy, SWOT and Corporate Finance Report Summary Vera Bradley Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Banca Del Ceresio SA:企業の戦略・SWOT・財務情報
    Banca Del Ceresio SA - Strategy, SWOT and Corporate Finance Report Summary Banca Del Ceresio SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • IRB Infrastructure Developers Ltd:企業の戦略・SWOT・財務情報
    IRB Infrastructure Developers Ltd - Strategy, SWOT and Corporate Finance Report Summary IRB Infrastructure Developers Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Marinus Pharmaceuticals Inc (MRNS):企業の財務・戦略的SWOT分析
    Summary Marinus Pharmaceuticals Inc (Marinus) is a clinical stage biopharmaceutical company that manufactures and commercializes therapeutics for the treatment of epilepsy, neuropsychiatric disorders and others diseases. The company’s pipeline product comprise ganaxolone is a CNS-selective GABAA mod …
  • NATS Holdings Limited:企業の戦略・SWOT・財務情報
    NATS Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary NATS Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • FANCL Corporation:企業の戦略・SWOT・財務情報
    FANCL Corporation - Strategy, SWOT and Corporate Finance Report Summary FANCL Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Alta Mesa Resources Inc:企業の戦略的SWOT分析
    Alta Mesa Resources Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Owens Corning:企業の戦略・SWOT・財務情報
    Owens Corning - Strategy, SWOT and Corporate Finance Report Summary Owens Corning - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Yale School of Medicine-製薬・医療分野:企業M&A・提携分析
    Summary Yale School of Medicine (YSM), a subsidiary of Yale University is an educational service provider that offers bio-medical research, education and advanced health care. The center provides degree programs such as public health program, physician associate program, other PhD programs, medical …
  • Hanger, Inc. (HNGR):企業の財務・戦略的SWOT分析
    Hanger, Inc. (HNGR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • HDI-Global SE:企業の戦略・SWOT・財務分析
    HDI-Global SE - Strategy, SWOT and Corporate Finance Report Summary HDI-Global SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Visioneering Technologies Inc (VTI):企業の製品パイプライン分析
    Summary Visioneering Technologies Inc (VTI) is a medical device company that offers ophthalmic solutions. It develops a portfolio of technologies to address eye care issues such as presbyopia, myopia and astigmatism. Its technology includes myopia correction technology, silicone hydrogel material pl …
  • CGI Group Inc (GIB.A):企業の財務・戦略的SWOT分析
    CGI Group Inc (GIB.A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Nando’s Chickenland Limited:企業の戦略的SWOT分析
    Nando's Chickenland Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Copart Inc (CPRT):企業の財務・戦略的SWOT分析
    Summary Copart Inc (Copart) carries out the provision of auctions and vehicle marketing services. The company offers sales and marketing of early and late model, hybrid, featured and seller certified vehicles. It markets vehicles which include ATVs, exotic and classic cars, boats, dirt bikes, trucks …
  • Antaros Medical AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Antaros Medical AB (Antaros Medical) is a drug development and technology company that offers innovative MRI and PET imaging techniques for decision making in clinical drug development. The company's services include small- to medium-sized studies, decision-making in Phase 1b and Phase 2 tri …
  • Gordon Ramsay Holdings Limited:企業の戦略・SWOT・財務情報
    Gordon Ramsay Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Gordon Ramsay Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Zion Oil & Gas Inc (ZN):企業の財務・戦略的SWOT分析
    Summary Zion Oil & Gas Inc (Zion Oil) is an oil and gas company that explores and produces oil and gas properties in Israel. The company offers services such as geophysical, geological, and other science-based studies and surveys to support oil and gas exploration and development services. It holds …
  • Compagnie Plastic Omnium SA (POM):企業の財務・戦略的SWOT分析
    Compagnie Plastic Omnium SA (POM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆